Please assess the completion status of the following clinical trial:

Trial Title: Seizure Prophylaxis in Aneurysm Repair

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult (≥18 years)~2. Presence of intracranial aneurysm (without rupture)~3. Treating surgeon has recommended surgical repair of the aneurysm.~Exclusion Criteria:~1. History of seizures within last 10 years~2. History of epilepsy~3. History of prior stroke~4. Currently prescribed medication with anti-epileptic activity (keppra,dilantin, tegretol, lamictal, topamax, etc.)~5. Brain tumor~6. Pregnant or nursing woman~7. Known levetiracetam allergy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Levetiracetam (Type: ACTIVE_COMPARATOR): None
- No anti-epileptic treatment (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).